Published in J Gen Virol on August 01, 1997
Evidence for budding of human immunodeficiency virus type 1 selectively from glycolipid-enriched membrane lipid rafts. J Virol (2000) 6.47
Lipid raft microdomains: a gateway for compartmentalized trafficking of Ebola and Marburg viruses. J Exp Med (2002) 3.88
Plunder and stowaways: incorporation of cellular proteins by enveloped viruses. J Virol (2005) 1.56
Retrovirus infection strongly enhances scrapie infectivity release in cell culture. EMBO J (2006) 1.53
Detection of antibody-dependent complement-mediated inactivation of both autologous and heterologous virus in primary human immunodeficiency virus type 1 infection. J Virol (2005) 1.31
Protein analysis of purified respiratory syncytial virus particles reveals an important role for heat shock protein 90 in virus particle assembly. Mol Cell Proteomics (2010) 1.27
Membrane cholesterol: a crucial molecule affecting interactions of microbial pathogens with mammalian cells. Infect Immun (2005) 1.22
A high-affinity inhibitor of human CD59 enhances complement-mediated virolysis of HIV-1: implications for treatment of HIV-1/AIDS. J Immunol (2009) 1.09
Cell surface expression of the vaccinia virus complement control protein is mediated by interaction with the viral A56 protein and protects infected cells from complement attack. J Virol (2008) 0.97
Complement and its role in protection and pathogenesis of flavivirus infections. Vaccine (2008) 0.96
Acquisition of complement resistance through incorporation of CD55/decay-accelerating factor into viral particles bearing baculovirus GP64. J Virol (2010) 0.93
The paramyxoviruses simian virus 5 and mumps virus recruit host cell CD46 to evade complement-mediated neutralization. J Virol (2009) 0.92
Incorporation of host complement regulatory proteins into Newcastle disease virus enhances complement evasion. J Virol (2012) 0.91
The resistance of retroviral vectors produced from human cells to serum inactivation in vivo and in vitro is primate species dependent. J Virol (1999) 0.89
The good and evil of complement activation in HIV-1 infection. Cell Mol Immunol (2010) 0.89
Dissecting the regions of virion-associated Kaposi's sarcoma-associated herpesvirus complement control protein required for complement regulation and cell binding. J Virol (2006) 0.89
Screening of complement inhibitors: shielded baculoviruses increase the safety and efficacy of gene delivery. Mol Ther (2010) 0.86
Human CD59 incorporation into porcine endogenous retrovirus particles: implications for the use of transgenic pigs for xenotransplantation. J Virol (2002) 0.85
Poxvirus complement control proteins are expressed on the cell surface through an intermolecular disulfide bridge with the viral A56 protein. J Virol (2010) 0.83
Reduced sensitivity to human serum inactivation of enveloped viruses produced by pig cells transgenic for human CD55 or deficient for the galactosyl-alpha(1-3) galactosyl epitope. J Virol (2004) 0.83
Virion-associated complement regulator CD55 is more potent than CD46 in mediating resistance of mumps virus and vesicular stomatitis virus to neutralization. J Virol (2012) 0.82
Induction of ebolavirus cross-species immunity using retrovirus-like particles bearing the Ebola virus glycoprotein lacking the mucin-like domain. Virol J (2012) 0.81
The nucleoside triphosphate diphosphohydrolase-1/CD39 is incorporated into human immunodeficiency type 1 particles, where it remains biologically active. J Mol Biol (2007) 0.80
Complement and HIV-I infection/HIV-associated neurocognitive disorders. J Neurovirol (2014) 0.80
A novel approach to inhibit HIV-1 infection and enhance lysis of HIV by a targeted activator of complement. Virol J (2009) 0.79
Provirus activation plus CD59 blockage triggers antibody-dependent complement-mediated lysis of latently HIV-1-infected cells. J Immunol (2014) 0.78
Effect of complement on HIV-2 plasma antiviral activity is intratype specific and potent. J Virol (2012) 0.78
Major chimpanzee-specific structural changes in sperm development-associated genes. Funct Integr Genomics (2011) 0.78
Cellular proteins associated with the interior and exterior of vesicular stomatitis virus virions. PLoS One (2014) 0.78
The mystery behind membrane insertion: a review of the complement membrane attack complex. Philos Trans R Soc Lond B Biol Sci (2017) 0.78
Diverse viral glycoproteins as well as CD4 co-package into the same human immunodeficiency virus (HIV-1) particles. Retrovirology (2014) 0.77
Immune Protection of Retroviral Vectors Upon Molecular Painting with the Complement Regulatory Protein CD59. Mol Biotechnol (2016) 0.76
Purification of infectious human herpesvirus 6A virions and association of host cell proteins. Virol J (2007) 0.76
Separation of decay-accelerating and cofactor functional activities of Kaposi's sarcoma-associated herpesvirus complement control protein using monoclonal antibodies. Immunology (2007) 0.76
A novel factor I activity in Nipah virus inhibits human complement pathways through cleavage of C3b. J Virol (2014) 0.76
Biomedical applications of glycosylphosphatidylinositol-anchored proteins. J Lipid Res (2016) 0.75
Glycosylphosphatidylinositol Anchor Deficiency Attenuates the Production of Infectious HIV-1 and Renders Virions Sensitive to Complement Attack. AIDS Res Hum Retroviruses (2016) 0.75
Association of complement receptor 2 polymorphisms with innate resistance to HIV-1 infection. Genes Immun (2015) 0.75
Evasion and interactions of the humoral innate immune response in pathogen invasion, autoimmune disease, and cancer. Clin Immunol (2015) 0.75
Caveolae provide a specialized membrane environment for respiratory syncytial virus assembly. J Cell Sci (2017) 0.75
A novel trifunctional IgG-like bispecific antibody to inhibit HIV-1 infection and enhance lysis of HIV by targeting activation of complement. Virol J (2010) 0.75
Complement Evasion Strategies of Viruses: An Overview. Front Microbiol (2017) 0.75
V1V2-specific complement activating serum IgG as a correlate of reduced HIV-1 infection risk in RV144. PLoS One (2017) 0.75
Membrane cofactor protein (MCP or CD46): newest member of the regulators of complement activation gene cluster. Annu Rev Immunol (1991) 4.27
Decay-accelerating factor: biochemistry, molecular biology, and function. Annu Rev Immunol (1989) 3.20
Hereditary angioedema: the clinical syndrome and its management. Ann Intern Med (1976) 3.10
Purification and characterization of a membrane protein (gp45-70) that is a cofactor for cleavage of C3b and C4b. J Exp Med (1986) 2.94
Measles virus spread and pathogenesis in genetically modified mice. J Virol (1998) 2.84
Molecular cloning and chromosomal localization of human membrane cofactor protein (MCP). Evidence for inclusion in the multigene family of complement-regulatory proteins. J Exp Med (1988) 2.75
Receptors for immunoglobulin and complement on human alveolar macrophages. J Immunol (1975) 2.74
Membrane cofactor protein (MCP or CD46) is a cellular pilus receptor for pathogenic Neisseria. Mol Microbiol (1997) 2.67
The regulators of complement activation (RCA) gene cluster. Adv Immunol (1989) 2.63
Cloning and characterization of cDNAs encoding the complete sequence of decay-accelerating factor of human complement. Proc Natl Acad Sci U S A (1987) 2.62
Control of the complement system. Adv Immunol (1996) 2.43
Relationship of the functional recovery after hip arthroplasty to the neuroendocrine and inflammatory responses. Br J Anaesth (2001) 2.43
Polymorphism of human erythrocyte C3b/C4b receptor. Proc Natl Acad Sci U S A (1983) 2.30
Role of virion-associated glycosylphosphatidylinositol-linked proteins CD55 and CD59 in complement resistance of cell line-derived and primary isolates of HIV-1. J Exp Med (1995) 2.12
Human genes for three complement components that regulate the activation of C3 are tightly linked. J Exp Med (1985) 2.12
Identification of an additional class of C3-binding membrane proteins of human peripheral blood leukocytes and cell lines. Proc Natl Acad Sci U S A (1985) 2.11
Multiple isoforms of CD46 (membrane cofactor protein) serve as receptors for measles virus. Proc Natl Acad Sci U S A (1994) 2.08
Systemic capillary leak syndrome and monoclonal IgG gammopathy; studies in a sixth patient and a review of the literature. Medicine (Baltimore) (1977) 2.07
Isolation and characterization of a membrane protein from normal human erythrocytes that inhibits reactive lysis of the erythrocytes of paroxysmal nocturnal hemoglobinuria. J Clin Invest (1989) 2.01
Membrane cofactor protein (CD46) is a keratinocyte receptor for the M protein of the group A streptococcus. Proc Natl Acad Sci U S A (1995) 1.86
Dissecting sites important for complement regulatory activity in membrane cofactor protein (MCP; CD46). J Biol Chem (2000) 1.84
Group B streptococci inhibit the chemotactic activity of the fifth component of complement. J Immunol (1988) 1.83
Molecular characterization of the Ss and Slp (C4) proteins of the mouse H-2 complex: subunit composition, chain size polymorphism, and an intracellular (PRO-Ss) precursor. J Immunol (1978) 1.75
Herpes simplex virus glycoproteins gC-1 and gC-2 bind to the third component of complement and provide protection against complement-mediated neutralization of viral infectivity. J Exp Med (1987) 1.74
Membrane cofactor protein of complement is present on human fibroblast, epithelial, and endothelial cells. J Clin Invest (1989) 1.70
Evaluation of the TREX1 gene in a large multi-ancestral lupus cohort. Genes Immun (2011) 1.70
Functional properties of membrane cofactor protein of complement. Biochem J (1989) 1.68
Polymorphism of the human C3b/C4b receptor. Identification of a third allele and analysis of receptor phenotypes in families and patients with systemic lupus erythematosus. J Exp Med (1984) 1.68
Decay-accelerating factor functions as a signal transducing molecule for human T cells. J Immunol (1988) 1.67
Complement factor C3 deposition and serum resistance in isogenic capsule and lipooligosaccharide sialic acid mutants of serogroup B Neisseria meningitidis. Infect Immun (1997) 1.65
Measles virus and C3 binding sites are distinct on membrane cofactor protein (CD46). Proc Natl Acad Sci U S A (1995) 1.64
Contribution of the repeating domains of membrane cofactor protein (CD46) of the complement system to ligand binding and cofactor activity. J Immunol (1991) 1.63
Bladder toxicity with chronic oral cyclophosphamide therapy in nonmalignant disease. Arthritis Rheum (1973) 1.61
Membrane cofactor protein (MCP; CD46): isoform-specific tyrosine phosphorylation. J Immunol (2000) 1.59
The effect of Bacillus Calmette-Guerin-induced macrophage activation on the in vivo clearance of sensitized erythrocytes. J Clin Invest (1974) 1.58
Distribution of membrane cofactor protein of complement on human peripheral blood cells. An altered form is found on granulocytes. Eur J Immunol (1988) 1.55
Paroxysmal nocturnal haemoglobinuria. Clin Haematol (1985) 1.55
Studies on the in vivo effects of antibody. Interaction of IgM antibody and complement in the immune clearance and destruction of erythrocytes in man. J Clin Invest (1974) 1.54
Hereditary vascular retinopathy, cerebroretinal vasculopathy, and hereditary endotheliopathy with retinopathy, nephropathy, and stroke map to a single locus on chromosome 3p21.1-p21.3. Am J Hum Genet (2001) 1.54
Induction of a transient elevation in intracellular levels of adenosine-3',5'-cyclic monophosphate by chemotactic factors: an early event in human neutrophil activation. J Immunol (1980) 1.54
Mapping of the region of complement receptor (CR) 1 required for Plasmodium falciparum rosetting and demonstration of the importance of CR1 in rosetting in field isolates. J Immunol (2000) 1.48
Structure-function relationships of complement receptor type 1. Immunol Rev (2001) 1.47
Binding of measles virus to membrane cofactor protein (CD46): importance of disulfide bonds and N-glycans for the receptor function. J Virol (1994) 1.46
The human cell-surface glycoproteins HuLy-m5, membrane co-factor protein (MCP) of the complement system, and trophoblast leucocyte-common (TLX) antigen, are CD46. Immunology (1990) 1.45
Neuroleukin: a lymphokine product of lectin-stimulated T cells. Science (1986) 1.44
Structural heterogeneity of the C3b/C4b receptor (Cr 1) on human peripheral blood cells. J Exp Med (1983) 1.43
Biosynthesis and glycosylation of the human complement regulatory protein decay-accelerating factor. J Immunol (1986) 1.41
Membrane cofactor protein (MCP; CD46). Isoforms differ in protection against the classical pathway of complement. J Immunol (1996) 1.41
The role of complement in the clearance of cold agglutinin-sensitized erythrocytes in man. J Clin Invest (1976) 1.40
Characterization of three monoclonal antibodies to membrane co-factor protein (MCP) of the complement system and quantification of MCP by radioassay. Clin Exp Immunol (1991) 1.39
Genetic variation in glycosylation of the fourth component of murine complement. Association with hemolytic activity. J Biol Chem (1982) 1.39
Susceptibility of HIV-1 plasma virus to complement-mediated lysis. Evidence for a role in clearance of virus in vivo. J Immunol (1996) 1.39
Membrane cofactor protein (CD46) protects cells from complement-mediated attack by an intrinsic mechanism. J Exp Med (1992) 1.38
Sites within the complement C3b/C4b receptor important for the specificity of ligand binding. Proc Natl Acad Sci U S A (1991) 1.34
Decay-accelerating factor and membrane cofactor protein. Curr Top Microbiol Immunol (1990) 1.34
Polymorphism of the C3b/C4b receptor (CR1): characterization of a fourth allele. J Immunol (1985) 1.33
Increased enzymatic activity of the alternative pathway convertase when bound to the erythrocytes of paroxysmal nocturnal hemoglobinuria. J Clin Invest (1982) 1.32
CD4-Negative cells bind human immunodeficiency virus type 1 and efficiently transfer virus to T cells. J Virol (2000) 1.31
Interaction of mannose-binding lectin with primary isolates of human immunodeficiency virus type 1. J Gen Virol (2000) 1.30
Improved cell surface radioiodination of macrophages. J Immunol Methods (1980) 1.30
CD11b/CD18 integrin and a beta-glucan receptor act in concert to induce the synthesis of platelet-activating factor by monocytes. J Immunol (1994) 1.30
Membrane cofactor protein: importance of N- and O-glycosylation for complement regulatory function. J Immunol (1998) 1.30
The gene encoding decay-accelerating factor (DAF) is located in the complement-regulatory locus on the long arm of chromosome 1. J Exp Med (1987) 1.29
A polymorphism of the complement regulatory protein MCP (membrane cofactor protein or gp45-70). J Immunol (1987) 1.28
Membrane cofactor protein (CD46) protects cells predominantly from alternative complement pathway-mediated C3-fragment deposition and cytolysis. J Immunol (1993) 1.25
Molecular identification of Knops blood group polymorphisms found in long homologous region D of complement receptor 1. Blood (2001) 1.25
Functional domains, structural variations and pathogen interactions of MCP, DAF and CR1. Immunopharmacology (2000) 1.25
Isolation of a biologically active macrophage receptor for the third component of complement. Nature (1981) 1.24
Analysis of the functional domains of complement receptor type 1 (C3b/C4b receptor; CD35) by substitution mutagenesis. J Biol Chem (1994) 1.24
Pediatric and adolescent gynecology. I. Fundamental considerations. Gross anatomy. Ann N Y Acad Sci (1967) 1.24
Effects of corticosteroids and splenectomy on the immune clearance and destruction of erythrocytes. J Clin Invest (1973) 1.24
Purification and functional analysis of the polymorphic variants of the C3b/C4b receptor (CR1) and comparison with H, C4b-binding protein (C4bp), and decay accelerating factor (DAF). J Immunol (1985) 1.23
Decay accelerating activity of complement receptor type 1 (CD35). Two active sites are required for dissociating C5 convertases. J Biol Chem (1999) 1.22
Diagnosis and management of hereditary angioedema (HAE). Ann Allergy (1979) 1.21
Attachment of Neisseria gonorrhoeae to the cellular pilus receptor CD46: identification of domains important for bacterial adherence. Cell Microbiol (2001) 1.21
Differential expression of the complement regulatory proteins in the human eye. Invest Ophthalmol Vis Sci (1993) 1.20
Comparison of binding characteristics of factors B and H to C3b on normal and paroxysmal nocturnal hemoglobinuria erythrocytes. J Immunol (1983) 1.20
Ligand binding specificity of a rabbit alveolar macrophage receptor for C3b. J Biol Chem (1982) 1.19
Identification of a third component of complement-binding glycoprotein of human platelets. J Clin Invest (1986) 1.17
Membrane cofactor protein. Curr Top Microbiol Immunol (1992) 1.17
Purification of the proteinase from group B streptococci that inactivates human C5a. Biochim Biophys Acta (1991) 1.17
Identification of an alternative polyadenylation site in the human C3b/C4b receptor (complement receptor type 1) transcriptional unit and prediction of a secreted form of complement receptor type 1. J Exp Med (1988) 1.16
Membrane cofactor protein (MCP; CD46) expression in transgenic mice. Clin Exp Immunol (2001) 1.16
The regulation of platelet-activating factor production in endothelial cells. The role of calcium and protein kinase C. J Biol Chem (1989) 1.16
Bacterial vaginosis-associated microflora isolated from the female genital tract activates HIV-1 expression. J Acquir Immune Defic Syndr (1999) 1.15
Structural heterogeneity of C2 Complement protein and its genetic variants in man: a new polymorphism of the HLA region. Proc Natl Acad Sci U S A (1977) 1.14
Cooperation between decay-accelerating factor and membrane cofactor protein in protecting cells from autologous complement attack. J Immunol (2000) 1.14
Normal polymorphic variations and transcription of the decay accelerating factor gene in paroxysmal nocturnal hemoglobinuria cells. Proc Natl Acad Sci U S A (1988) 1.14
Erythrocyte membrane inhibitor of reactive lysis: effects of phosphatidylinositol-specific phospholipase C on the isolated and cell-associated protein. Blood (1990) 1.13
Characterization of the complement sensitivity of paroxysmal nocturnal hemoglobinuria erythrocytes. J Clin Invest (1985) 1.12
Influence of glycosylation on allelic and cell-specific Mr variation, receptor processing, and ligand binding of the human complement C3b/C4b receptor. J Biol Chem (1986) 1.12
The N-glycan of the SCR 2 region is essential for membrane cofactor protein (CD46) to function as a measles virus receptor. J Virol (1996) 1.12
Membrane cofactor protein (CD46) of complement. Processing differences related to alternatively spliced cytoplasmic domains. J Biol Chem (1994) 1.12
Biochemical characterization of membrane cofactor protein of the complement system. J Immunol (1988) 1.12